Biosensors using field-effect transistors show great promise

Biosensors using field-effect transistors show great promise
Electrolyte-gated carbon nanotube field-effect transistor-based biosensors show promise for many applications. Credit: Raheel Riaz

Demand for sensitive and selective electronic biosensors—analytical devices that monitor a target of interest in real time—is growing for a wide range of applications. They are ideal for health care within clinical settings, drug discovery, food safety and quality control, and environmental monitoring.

Electronic biosensors are appealing due to their simplicity, short analysis time, low fabrication cost, minimal sample preparation, and potential to be used out in the field by untrained personnel.

In Applied Physics Reviews, Free University of Bozen-Bolzano and ETH Zurich researchers review scientific advances of electrolyte-gated field-effect transistor (EG-CNTFET) biosensors. These devices are characterized by superior electronic properties and intrinsic signal amplification and are capable of detecting a wide range of biomolecules with .

One of the main components of a is its biorecognition element, such as enzymes, antibodies, aptamers, or ion-selective membranes, which selectively recognizes the (a substance whose chemicals are measured and identified) of interest. Biotransduction devices convert the interaction between the biorecognition element and analyte into a measurable signal, such as an .

"Biosensors using () as biotransduction elements are one of the most promising devices for biosensing applications, because they have already demonstrated high sensitivities toward several analytes down to picomolar concentration," said Mattia Petrelli, from Free University of Bozen-Bolzano. "Among all the possible materials that can be used for FET-based biosensors, semiconducting carbon nanotubes are interesting, because they have favorable electrical and chemical properties."

By organizing these biosensors with different biorecognition elements, "it is possible to achieve selective detection of different analytes, such as biomolecules, cancer biomarkers, bacteria, and ions to name only a few," said Petrelli. "Despite reports that demonstrate the potential translation of these biosensors to real-world applications, challenges must be overcome before they are commercially available."

EG-CNTFET-based biosensors are currently capable of detecting only one analyte at a time. Different interfaces within complex media, such as blood, sweat, or saliva, also make detection of specific signals challenging.

"This limits the applicability of these biosensors for real-life applications," Petrelli said. "The selectivity of the device should be carefully evaluated against all possible interfering agents, especially within complex detection environments. Once these challenges are tackled, we can envision these biosensors being implemented for diverse applications within the near future."

More information: Electrolyte-gated carbon nanotube field-effect-transistor-based biosensors: Principles and applications, Applied Physics Reviews, DOI: 10.1063/5.0058591

Journal information: Applied Physics Reviews

Citation: Biosensors using field-effect transistors show great promise (2021, December 21) retrieved 25 February 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

New biosensors measure toxic drugs in cancer, arthritis, and organ transplant patients


Feedback to editors